• Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye

  2026-09-12

  Sulfo-Cy3 NHS Ester is a hydrophilic fluorescent dye for aqueous labeling of primary amines in proteins and peptides. Its sulfonated structure, Cy3 spectral profile, and NHS ester chemistry support protein conjugation workflows for soluble and challenging biomolecular targets.

• Cy5 amine (non-sulfonated): Labeling Guide

  2026-09-11

  Cy5 amine (non-sulfonated) provides a primary amine for covalent attachment of a red-shifted cyanine fluorophore to activated biomolecule partners. It is suited to organic or mixed-solvent labeling workflows, but is insoluble in water and should not be used for direct aqueous dissolution, diagnostic testing, or medical applications.

• Griseofulvin: From Fungal Mitosis to Assays

  2026-09-11

  Explore how Griseofulvin functions as a microtubule associated inhibitor and how mechanism-resolved cytometry can sharpen antifungal drug research. This guide connects product handling, fungal mitosis biology, and aneugenic assay interpretation without conflating distinct experimental domains.

• Haloprogin: Applied Antifungal Research Workflows

  2026-09-10

  Haloprogin supports reproducible profiling across dermatophytes, Candida, and selected Gram-positive bacteria, with workflows spanning MIC/MFC testing and topical infection models. Its solvent, matrix, and formulation behavior make assay design especially important when translating in vitro potency into topical efficacy.

• rTMS, GABAergic Neurons, and Amyloid Clearance in AD

  2026-09-10

  This study identifies a cellular pathway linking repetitive transcranial magnetic stimulation to amyloid clearance and cognitive recovery in a 5xFAD Alzheimer’s disease model. Its central finding is that rTMS activates GABAergic neurons, increases Cx3cl1-Cx3cr1 signalling, and promotes microglial phagocytosis while reducing plaque burden and neuroinflammatory features.

• Cy5 Maleimide for Protein Labeling and Condensate Imaging

  2026-09-09

  Cy5 maleimide enables site-selective cysteine labeling for far-red protein tracking, microscopy, and biomolecular-condensate assays. Its non-sulfonated format is especially useful when researchers need to test how fluorophore chemistry influences molecular partitioning rather than treating every dye as an inert tag.

• Ciprofloxacin Hydrochloride: Mechanism and Uses

  2026-09-09

  Ciprofloxacin hydrochloride is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV. Evidence also supports research into inhalational anthrax treatment, antibiotic-combination antagonism, and immunomodulatory effects, but animal and in vitro findings do not establish new clinical indications.

• A-1331852: Precision BCL-XL Inhibition

  2026-09-08

  A-1331852 is a selective BCL-XL inhibitor for mapping apoptotic dependence, validating BCL-XL–BIM complex disruption, and testing senolytic strategies in cancer models. This guide translates published BH3-mimetic findings into practical dose-response, apoptosis, and troubleshooting workflows.

• hCG, H3K27 Methylation, and CXCL10 in Decidua

  2026-09-08

  The reference study shows that human chorionic gonadotropin suppresses CXCL10 in human decidual stromal cells by promoting EZH2-dependent H3K27 trimethylation at the CXCL10 promoter. This connects placental endocrine signaling with chromatin control of immune-cell recruitment and provides a mechanistic framework for studying maternal–fetal immune tolerance.

• Biotin-16-UTP: From RNA Labels to Mechanism

  2026-09-07

  Biotin-16-UTP connects biotin-labeled RNA synthesis with mechanistic questions in cancer biology. Using the LINC02870–EIF4G1–SNAIL axis in hepatocellular carcinoma as an anchor, this article outlines how translational researchers can use affinity-enabled RNA workflows to validate RNA-protein interactions while managing assay, interpretation, and clinical-translation risks.

• BAY-826: A Causal Lens on Retinal Signaling

  2026-09-07

  Retinal neurovascular biology is increasingly understood as a coordinated conversation among angiopoietin signaling, Müller cells, PEDF, and neuronal survival. This thought-leadership article positions BAY-826 as a hypothesis-testing research tool rather than an assumed pathway solution, outlining how translational teams can connect chemical perturbation to target engagement, co-culture phenotypes, and causal rescue experiments.

• RNASEH1-AS1 as an HCC Biomarker

  2026-09-05

  The reference study integrates TCGA-based bioinformatics, risk modeling, and cell-based validation to identify RNASEH1-AS1 as a prognostic and potentially oncogenic lncRNA in hepatocellular carcinoma. Its findings connect RNASEH1-AS1 expression with tumor grade, survival, immune-cell infiltration, ribosome-related gene networks, and DKC1-dependent RNA stability, while also defining experimental directions for further mechanistic work.

• AI-10-49: An Assay-First AML Strategy

  2026-09-04

  AI-10-49 is a selective CBFβ-SMMHC inhibitor for dissecting fusion-driven acute myeloid leukemia. This assay-first guide connects target engagement, RUNX1 chromatin restoration, and the N-MYC/eIF4G1 survival program to practical experimental decisions.

• Gramine–MTDH Ferroptosis in Triple-Negative Breast Cancer

  2026-09-04

  This study identifies gramine as a potential inhibitor of triple-negative breast cancer and defines a CUL3–MTDH regulatory mechanism that promotes ferroptosis. Its combination of chemical screening, target-validation assays, ferroptosis rescue experiments, and tumor models provides a useful framework for studying ubiquitin-regulated cell death in TNBC.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody Guide

  2026-09-03

  The Cy5 Goat Anti-Mouse IgG (H+L) Antibody is a Cy5-conjugated secondary antibody for sensitive mouse IgG detection in IHC, ICC, and flow cytometry. Its affinity-purified polyclonal design supports signal amplification, while defined buffer and storage conditions guide reproducible handling.

7784 records 1/519 page Next 12345 下5页 Last page